Abstract
Our purpose was to develop a self-microemulsifying drug delivery system (SMEDDS) to enhance oral absorption of β-elemene and evaluate its oral bioavailability in rats. Pseudo-ternary phase diagrams were constructed to identify the efficient self-microemulsification region. SMEDDS formulations were further optimized by measurement of mean droplet size and emulsification time. The in vitro release profile of SMEDDS was determined in different aqueous media. The optimal formulation, which consisted of 10 % Miglyol 812, 41.7 % Cremophor EL, 8.3 % Labrasol, 20 % Transcutol P and 200 mg/g β-elemene, demonstrated a higher release rate in simulated gastric fluid than emulsion and pure drug. In vivo studies showed that the relative bioavailability in rats of SMEDDS versus emulsion was 161.35 %. The C max for SMEDDS was also significantly higher than that of emulsion (P
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
